Dario Marchetti, PhD

Dario Marchetti, PhD

Faculty Titles
Professor, Division of Molecular Medicine
UNM Department of Internal Medicine
Professor, UNM Department of Pathology
Visiting Professor, Baylor College of Medicine, Texas

Research Program
Cancer Therapeutics: Technology, Discovery and Targeted Delivery

Call for an appointment:
Phone: (505) 272-7937
E-mail: dmarchetti@salud.unm.edu

Additional Languages
Italian, Spanish

Graduate School
The University of Pavia, Pavia, Italy, 1979

Visit for More Information
Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Dario+Marchetti

Personal Statement

Dr. Marchetti, tumor and molecular biologist, is an international authority in the characterization of patient-isolated Circulating Tumor Cells (CTCs), CTC biomarkers, and CTC testing implementing “liquid biopsy” concepts as clinically useful tools to combat cancer metastasis. With keen insights into the biology of brain metastasis, he pioneered discovery of CTC signatures underlying brain metastasis and biomarker properties of brain-homing/brain-associated CTCs (Science Transl. Med., 2013; Nature Comm., 2017; Nat. Rev. Clin. Onc., 2017; along others).

As a consummate scientist, Dr. Marchetti’s bibliography include 185 publications of which 79 are in peer-reviewed journals in the fields of neuroscience and oncology. He has received numerous awards and secured uninterrupted funding for 28 years from federal, state, institutional and private agencies. He is a reviewer for the most prominent journals in cancer research and sits on numerous editorial boards. He also acts as Guest Editor of special issues on brain metastasis and CTCs as cancer diagnostics biomarkers. Further, he serves/d on grant reviewing panels of NIH of USA and Italy, US DoD-CDMRP, and is frequently invited as reviewer and consultant for national and international agencies.

Dr. Marchetti graduated from the University of Pavia (Italy) in 1979. He worked as postdoctoral fellow at the University of Illinois-Chicago (1980-1982), University of Texas Medical Branch – Galveston (1984-1986). He then became research scientist at the University of Texas-Houston (1986-1991), Research Associate and later Instructor at MD Anderson Cancer Center (1992-1999), Assistant Professor at UT-Houston (1999-2001), Associate Professor and later Professor (with tenure) at LSU-Baton Rouge (2002-2007), endowed “Jack. L. Titus” Professor (with tenure) at Baylor College of Medicine (2008-2015; now Visiting Professor), and Professor and Director of the Biomarker Research Program Center at Houston Methodist (2015-2019), prior to joining the University of New Mexico Health Sciences Center.